Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2006, p. 47-50, Vol. 44, No. 1
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.1.47-50.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Laboratoire de Génétique Humaine des Maladies Infectieuses, Faculté Necker, Université de Paris René Descartes INSERM U550, Paris, France,1 Service d'Hématologie, Immunologie biologiques, Hôpital Bicêtre, Le Kremlin-Bicêtre, France,2 Laboratoire de Virologie, Hôpital Tenon, Paris, France,3 Service d'Onco-hématologie, Hôpital Saint-Louis, Paris, France,4 Département d'Hématologie, Institut Gustave Roussy, Paris, France,5 Service d'Hématologie adultes, Hôpital Necker, Paris, France6
Received 7 July 2005/ Returned for modification 22 September 2005/ Accepted 8 October 2005
Markers of Epstein-Barr virus (EBV) infection include measures of specific serological titers and of viral load (VLo) in peripheral blood mononuclear cells. Few studies have investigated the correlation between these two phenotypes. Here, we found that there was no correlation between VLo and either anti-EBV nuclear antigen type 1 or anti-early antigen immunoglobulin G (IgG) titer but that anti-viral capsid antigen (VCA) IgG titer increased with VLo in peripheral blood mononuclear cells in patients with Hodgkin's lymphoma (P = 3.103). A similar pattern was observed in healthy first-degree relatives (parents and siblings) of patients (P = 6.104). Our results indicate that anti-VCA IgG titers and EBV VLo are specifically correlated EBV phenotypes.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»